Literature DB >> 9129037

Cloning and characterization of exodus, a novel beta-chemokine.

R Hromas1, P W Gray, D Chantry, R Godiska, M Krathwohl, K Fife, G I Bell, J Takeda, S Aronica, M Gordon, S Cooper, H E Broxmeyer, M J Klemsz.   

Abstract

Chemokines are a family of related proteins that regulate leukocyte infiltration into inflamed tissue. Some chemokines such as MIP-1 alpha also inhibit hematopoietic progenitor cell proliferation. Recently, three chemokines, MIP-1 alpha, MIP-1 beta, and RANTES, have been found to significantly decrease human immunodeficiency virus production from infected T cells. We report here the cloning and characterization of a novel human chemokine termed Exodus for its chemotactic properties. This novel chemokine is distantly related to other chemokines (28% homology with MIP-1 alpha) and shares several biological activities. Exodus is expressed preferentially in lymphocytes and monocytes, and its expression is markedly upregulated by mediators of inflammation such as tumor necrosis factor or lipopolysaccharide. Purified synthetic Exodus was found to inhibit proliferation of myeloid progenitors in colony formation assays. Exodus also stimulated chemotaxis of peripheral blood mononuclear cells. The sequence homology, expression, and biological activity indicate that Exodus represents a novel divergent beta-chemokine.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9129037

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  47 in total

Review 1.  Immune chemokines and their receptors: the key elements in the genesis, homeostasis and function of the immune system.

Authors:  O Yoshie
Journal:  Springer Semin Immunopathol       Date:  2000

2.  CCR6-deficient mice have impaired leukocyte homeostasis and altered contact hypersensitivity and delayed-type hypersensitivity responses.

Authors:  R Varona; R Villares; L Carramolino; I Goya ; A Zaballos ; J Gutiérrez; M Torres; C Martínez-A; G Márquez
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

3.  Computationally identifying novel NF-kappa B-regulated immune genes in the human genome.

Authors:  Rongxiang Liu; Richard C McEachin; David J States
Journal:  Genome Res       Date:  2003-03-12       Impact factor: 9.043

4.  Gene expression profiling in fetal, aged, and Alzheimer hippocampus: a continuum of stress-related signaling.

Authors:  Walter J Lukiw
Journal:  Neurochem Res       Date:  2004-06       Impact factor: 3.996

5.  The CCR6/CCL20 axis mediates Th17 cell migration to the ocular surface in dry eye disease.

Authors:  Thomas H Dohlman; Sunil K Chauhan; Shilpa Kodati; Jing Hua; Yihe Chen; Masahiro Omoto; Zahra Sadrai; Reza Dana
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-06-12       Impact factor: 4.799

6.  Many Roles of CCL20: Emphasis on Breast Cancer.

Authors:  Kingsley O Osuala; Bonnie F Sloane
Journal:  Postdoc J       Date:  2014-03

Review 7.  Chemokines: understanding their role in T-lymphocyte biology.

Authors:  S G Ward; J Westwick
Journal:  Biochem J       Date:  1998-08-01       Impact factor: 3.857

Review 8.  Dendritic cell biology and regulation of dendritic cell trafficking by chemokines.

Authors:  C Caux; S Ait-Yahia; K Chemin; O de Bouteiller; M C Dieu-Nosjean; B Homey; C Massacrier; B Vanbervliet; A Zlotnik; A Vicari
Journal:  Springer Semin Immunopathol       Date:  2000

9.  The chemokine CCL20 induces proinflammatory and matrix degradative responses in cartilage.

Authors:  Nada Alaaeddine; John Antoniou; Mayssam Moussa; George Hilal; Gaby Kreichaty; Ismat Ghanem; Wissam Abouchedid; Elie Saghbini; John A Di Battista
Journal:  Inflamm Res       Date:  2015-07-20       Impact factor: 4.575

10.  Tumor-associated macrophages recruit CCR6+ regulatory T cells and promote the development of colorectal cancer via enhancing CCL20 production in mice.

Authors:  Jinlin Liu; Ning Zhang; Qun Li; Weiwei Zhang; Fang Ke; Qibin Leng; Hong Wang; Jinfei Chen; Honglin Wang
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.